Hengrui Medicine (01276): RSS0393 ointment approved for clinical trials.

Cnstock News APP News, Hengrui Medicine (01276) announced that recently, its subsidiary Ruishi Biopharmaceutical Co., Ltd. received the Drug Clinical Trial Approval Notification Letter issued by the National Medical Products Administration (referred to as "NMPA"), approving the clinical trial of the RSS0393 ointment, which will be conducted soon.